应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06667 美因基因
未开盘 07-02 09:03:16
7.110
+0.000
0.00%
最高
7.110
最低
7.110
成交量
0.00
今开
7.110
昨收
7.110
日振幅
0.00%
总市值
15.93亿
流通市值
15.93亿
总股本
2.24亿
成交额
0.00
换手率
0.00%
流通股本
2.24亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
美因基因更新6月股份变动月报表,总股本保持不变
公告速递 · 07-02 20:06
美因基因更新6月股份变动月报表,总股本保持不变
美因基因回购4400股股份,总额约3.13万港元
公告速递 · 06-30 17:42
美因基因回购4400股股份,总额约3.13万港元
美因基因(06667)6月30日斥资约3.13万港元回购4400股
智通财经 · 06-30 17:37
美因基因(06667)6月30日斥资约3.13万港元回购4400股
美因基因回购2,000股股份,耗资约1.40万港元
公告速递 · 06-23
美因基因回购2,000股股份,耗资约1.40万港元
美因基因回购200股股份,总额约1,404港元
公告速递 · 06-22
美因基因回购200股股份,总额约1,404港元
美因基因(06667)6月22日耗资1404港元回购200股
智通财经 · 06-22
美因基因(06667)6月22日耗资1404港元回购200股
美因基因回购18,800股股份,涉资约11.63万港元
公告速递 · 06-17
美因基因回购18,800股股份,涉资约11.63万港元
美因基因(06667)6月17日斥资11.6万港元回购1.88万股
智通财经 · 06-17
美因基因(06667)6月17日斥资11.6万港元回购1.88万股
美因基因5月无新增发行或股份变动,股本维持稳定
公告速递 · 06-01
美因基因5月无新增发行或股份变动,股本维持稳定
美因基因宣派末期股息每股0.15元,6月23日派发
公告速递 · 05-27
美因基因宣派末期股息每股0.15元,6月23日派发
美因基因(06667)将于6月23日派发末期股息每股0.17港元
智通财经 · 05-27
美因基因(06667)将于6月23日派发末期股息每股0.17港元
美因基因更新末期股息派付时间表,每股0.15元人民币
公告速递 · 05-21
美因基因更新末期股息派付时间表,每股0.15元人民币
美因基因(06667)将于7月9日派发末期股息每股0.17港元
智通财经 · 05-21
美因基因(06667)将于7月9日派发末期股息每股0.17港元
美因基因4月无新增发行或股份变动
公告速递 · 05-05
美因基因4月无新增发行或股份变动
美因基因拟回购最多10%股份
公告速递 · 04-28
美因基因拟回购最多10%股份
美因基因将于2026年7月6日派发末期股息每股0.15元
公告速递 · 04-28
美因基因将于2026年7月6日派发末期股息每股0.15元
美因基因(06667)将于7月6日派发末期股息每股0.15元
智通财经 · 04-28
美因基因(06667)将于7月6日派发末期股息每股0.15元
美因基因(06667)2025年收入同比增五成 研发与多元化业务驱动基因检测布局深化
公告速递 · 04-27
美因基因(06667)2025年收入同比增五成 研发与多元化业务驱动基因检测布局深化
美因基因3月无新增发行或股份变动
公告速递 · 04-02
美因基因3月无新增发行或股份变动
美因基因(06667)公布2025年业绩 经调整净利润4197.4万元 同比增长6.9%
智通财经 · 03-31
美因基因(06667)公布2025年业绩 经调整净利润4197.4万元 同比增长6.9%
加载更多
公司概况
公司名称:
美因基因
所属市场:
SEHK
上市日期:
--
主营业务:
美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断(IVD)管线产品,包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":7.11,"timestamp":1782954196370,"preClose":7.11,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":224000000,"shares":224000000,"eps":0.1580966221619205,"marketStatus":"未开盘","change":0,"latestTime":"07-02 09:03:16","open":7.11,"high":7.11,"low":7.11,"amount":0,"amplitude":0,"askPrice":7.11,"askSize":6600,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.15364776835781566,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783042200000},"marketStatusCode":0,"adr":0,"listingDate":1655827200000,"exchange":"SEHK","adjPreClose":7.11,"dividendRate":0.023896,"openAndCloseTimeList":[[1782955800000,1782964800000],[1782968400000,1782979200000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06667","defaultTab":"news","newsList":[{"id":"1137608841","title":"美因基因更新6月股份变动月报表,总股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1137608841","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137608841?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:06","pubTimestamp":1782993993,"startTime":"0","endTime":"0","summary":"2026年7月2日,美因基因有限公司发布截至2026年6月30日的证券变动月报。公告显示,公司法定/注册股本仍为500,000,000股,每股面值USD 0.0001,合计USD 50,000,与上月保持一致。报告期内,公司已发行股份由224,300,200股减少至224,274,800股,减少数量为25,400股;相应地,库藏股于月内增加25,400股,从0升至25,400股。截至2026年6月30日,公司总股本为224,300,200股,未发生实质变化。公司表示,购回股份暂作为库藏股持有,已符合适用的最低公众持股量要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124166657","title":"美因基因回购4400股股份,总额约3.13万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124166657","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124166657?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:42","pubTimestamp":1782812579,"startTime":"0","endTime":"0","summary":"美因基因有限公司(股票代码:06667)于2026年6月30日发布公告,披露当日于香港联交所场内回购4400股普通股。此次回购每股价格为每股7.11港元,总金额约3.13万港元,约占回购前已发行股本的0.002%。\n此次交易完成后,公司已发行股本变更为224,274,800股,库藏股数量增至25,400股,而已发行股份总数则保持224,300,200股。公司于2026年5月21日通过回购授权,可回购股份总数为22,430,020股。截至公告日,累计回购总数达25,400股。\n公司在公告中确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规规定,并由董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购4400股股份,总额约3.13万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647316215","title":"美因基因(06667)6月30日斥资约3.13万港元回购4400股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647316215","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647316215?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:37","pubTimestamp":1782812235,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年6月30日该公司斥资约3.13万港元回购4400股,回购价格为每股7.11港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191788537","title":"美因基因回购2,000股股份,耗资约1.40万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191788537","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191788537?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:26","pubTimestamp":1782213999,"startTime":"0","endTime":"0","summary":"美因基因有限公司(股票代码:06667)于2026年6月23日公告进行股份回购。本次回购涉及普通股2,000股,占当日公司现有已发行股本约0.0009%。公司每股回购价为7.00港元,共动用资金约1.40万港元。\n本次回购完成后,公司已发行股本(不包括库藏股份)降至224,279,200股,库藏股份数增至21,000股。公司于2026年5月21日通过了回购授权,总数为22,430,020股,截至公告日已累计回购21,000股。\n公司董事会确认,上述回购过程符合香港联交所证券上市规则及相关法律、法规的规定。公告由董事姜晶签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购2,000股股份,耗资约1.40万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191417328","title":"美因基因回购200股股份,总额约1,404港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191417328","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191417328?lang=zh_cn&edition=full","pubTime":"2026-06-22 19:47","pubTimestamp":1782128830,"startTime":"0","endTime":"0","summary":"美因基因有限公司(06667)于2026年6月22日公告,公司在香港联交所场内回购200股普通股股份,占当日公司已发行股本约0.0001%。每股回购价为7.02港元,合计涉资约1,404港元。此次回购完成后,公司已发行股本变动为224,281,200股,库藏股数增至19,000股。\n公司披露,本次回购依据2026年5月21日通过的购回授权进行,授权可供回购股份数量为22,430,020股。截至公告日,合计回购股份数量为19,000股,约占相关授权通过当日已发行股本的0.0085%。公司同时确认已遵守香港联交所上市规则及其他相关法律规定。\n公告由公司董事姜晶签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购200股股份,总额约1,404港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645102106","title":"美因基因(06667)6月22日耗资1404港元回购200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645102106","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645102106?lang=zh_cn&edition=full","pubTime":"2026-06-22 19:45","pubTimestamp":1782128712,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)公布,2026年6月22日耗资1404港元回购200股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","06667","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121502749","title":"美因基因回购18,800股股份,涉资约11.63万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121502749","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121502749?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:56","pubTimestamp":1781697364,"startTime":"0","endTime":"0","summary":"美因基因有限公司(股票代码:06667)于2026年6月17日公告称,公司在香港联交所场内回购普通股18,800股,占决议通过当日已发行股本约0.0084%。本次回购最高价格为每股7.01港元,最低价格为每股5.80港元,合计耗资约11.63万港元。\n本次交易完成后,公司已发行股本(不包括库藏股)变更为224,281,400股,库藏股数量为18,800股,总股本仍为224,300,200股。公司此前于2026年5月21日获得购回授权,总可回购股份数为22,430,020股。本次交易已遵循联交所相关上市规则及适用法律法规,并获得公司董事会的正式授权。\n此次公告由董事姜晶签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因回购18,800股股份,涉资约11.63万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745349","title":"美因基因(06667)6月17日斥资11.6万港元回购1.88万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745349","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644745349?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:53","pubTimestamp":1781697192,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,于2026年6月17日斥资11.6万港元回购1.88万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136621926","title":"美因基因5月无新增发行或股份变动,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1136621926","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136621926?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:11","pubTimestamp":1780305094,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年6月1日披露截至2026年5月31日的证券变动月报表。报告显示,期内公司并未进行新增股份发行、购回、注销或库藏股活动,股本架构整体保持稳定。已发行股份方面,报告期末公司已发行股份总数为224,300,200股,库藏股份数量为0股,与上期持平并无增减。本次公告由董事姜晶签署。公司表示,公司的股份状况维持不变,将持续严格遵守监管规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170153799","title":"美因基因宣派末期股息每股0.15元,6月23日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1170153799","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170153799?lang=zh_cn&edition=full","pubTime":"2026-05-27 17:31","pubTimestamp":1779874315,"startTime":"0","endTime":"0","summary":"美因基因(06667)公布,已确定派发截至2025年12月31日止年度的末期股息,每股普通股0.15元人民币。股息派发日期此前已更新,现定于2026年6月23日向股东支付。\n公司将以预设货币每股0.17港元派发该笔股息,汇率为1元人民币兑1.15港元。凡于2026年5月29日记录日期登记在册的股东,均可获派末期股息。为符合分派资格,股东须于2026年5月27日下午4时30分前递交股份过户文件,相关过户登记手续将于2026年5月28日至5月29日期间暂停办理,除净日为2026年5月26日。\n公告显示,此次股息派发不涉及预扣所得税。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因宣派末期股息每股0.15元,6月23日派发","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638505303","title":"美因基因(06667)将于6月23日派发末期股息每股0.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638505303","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638505303?lang=zh_cn&edition=full","pubTime":"2026-05-27 17:26","pubTimestamp":1779873972,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)公布,将于2026年6月23日派发末期股息每股0.17港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446636.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VIG","EWH","BK4585","BK1219","06667","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107682576","title":"美因基因更新末期股息派付时间表,每股0.15元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1107682576","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107682576?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:35","pubTimestamp":1779352559,"startTime":"0","endTime":"0","summary":"美因基因发布更新公告,明确截至2025年12月31日止年度的末期股息派付时间表。此前的宣派方案已经股东批准,本次更新仅针对时间安排。公告显示,公司宣派末期普通股息为每股0.15元人民币,按1元人民币兑1.15港元的汇率换算,每股派发0.17港元。股息除净日定于2026年5月26日,股东须在2026年5月27日16时30分前递交股份过户文件,方可享有股息。股息最终派发日期为2026年7月9日。此次股息不涉及代扣所得税。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因更新末期股息派付时间表,每股0.15元人民币","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637853433","title":"美因基因(06667)将于7月9日派发末期股息每股0.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637853433","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637853433?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:33","pubTimestamp":1779352400,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,将于2026年7月9日派发截至2025年12月31日止年度的末期股息每股0.17港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VIG","EWH","BK4585","06667","BK1219","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119449258","title":"美因基因4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1119449258","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119449258?lang=zh_cn&edition=full","pubTime":"2026-05-05 13:46","pubTimestamp":1777959996,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年5月5日发布了截至2026年4月30日的证券变动月报表。根据月报数据,公司已发行普通股在4月底仅剩224,300,200股,与上个月持平,库存股为0股,报告期内未发生任何新增发行、回购、注销或转让变动。截至本月末,美因基因的整体股本保持稳定。公司表示,本报告期内所有证券相关活动均已严格遵守香港联交所《上市规则》及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154264497","title":"美因基因拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1154264497","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154264497?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:12","pubTimestamp":1777374746,"startTime":"0","endTime":"0","summary":"美因基因有限公司于2026年4月29日发布公告,拟向股东大会申请一般授权,可在会议通过当日已发行股份总数基础上,按最高不超过10%的比例回购公司股票。该公司截至最后实际可行日期已发行股本为224,300,200股,若股东大会通过且股本保持不变,最高回购数量为22,430,020股。根据公告,董事会仅会在有利于公司及股东的情况下,适时实施回购。公司计划在2026年5月21日召开股东周年大会,对回购授权进行表决。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173673744","title":"美因基因将于2026年7月6日派发末期股息每股0.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173673744","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173673744?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:11","pubTimestamp":1777374673,"startTime":"0","endTime":"0","summary":"美因基因(06667)于2026年4月29日发布最新公告,董事会宣布派发截至2025年12月31日止年度的末期股息,每股人民币0.15元,派发须待2026年5月21日股东大会批准后生效。\n根据公告,股息除净日为2026年5月26日,股东需在2026年5月27日16时30分前递交过户文件。公司将于2026年5月28日至5月29日暂停办理股份过户登记,并于2026年5月29日为股息派发的记录日期。股息将于2026年7月6日派发,以港元支付,具体汇率等待后续公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美因基因将于2026年7月6日派发末期股息每股0.15元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630303729","title":"美因基因(06667)将于7月6日派发末期股息每股0.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630303729","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630303729?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:04","pubTimestamp":1777374289,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因(06667)发布公告,将于2026年7月6日派发截至2025年12月31日止年度的末期股息每股0.15元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","BK4588","BK4585","VIG","06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186144600","title":"美因基因(06667)2025年收入同比增五成 研发与多元化业务驱动基因检测布局深化","url":"https://stock-news.laohu8.com/highlight/detail?id=1186144600","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186144600?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:09","pubTimestamp":1777288189,"startTime":"0","endTime":"0","summary":"美因基因于开曼群岛注册成立,并在香港联合交易所有限公司主板上市,现于北京海淀区及香港中环设有主要营业地点,主要从事消费级基因检测、癌症筛查服务与相关配套产品业务。报告期内,公司实现收入2.47亿元人民币,较2024年度的1.64亿元人民币同比增长约50.5%,创近五年新高;期间业绩增量主要来自消费级基因检测与癌症筛查服务规模的进一步拓展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美因基因(06667)2025年收入同比增五成 研发与多元化业务驱动基因检测布局深化","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144161847","title":"美因基因3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1144161847","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144161847?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:17","pubTimestamp":1775125057,"startTime":"0","endTime":"0","summary":"美因基因于2026年4月2日发布的截至2026年3月31日止股份变动月报显示,公司当月未进行任何新增发行、购回或注销股份活动,整体股本结构保持稳定。美因基因有限公司法定注册股本维持在500,000,000股,面值每股0.0001美元,合计50,000美元。根据公告,公司当月公开发行比例符合香港联交所相关规定。此外,公告内容显示公司本月无股份期权、权证及可换股票据等工具的新增或变动情况,也无其他形式的股份变动协议签订或执行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623914587","title":"美因基因(06667)公布2025年业绩 经调整净利润4197.4万元 同比增长6.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623914587","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623914587?lang=zh_cn&edition=full","pubTime":"2026-03-31 21:48","pubTimestamp":1774964930,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美因基因 公布2025年业绩,实现营业收入约2.47亿元,同比增长50.5%。净利润2702.1万元,同比减少40%;经调整净利润4197.4万元,同比增长6.9%。公告称,收入增长主要由于集团持续拓展产品品类、完善产品矩阵布局并优化整体业务结构,多重举措协同发力,有效驱动整体收入规模稳健提升。倘剔除上述金融资产减值变动及一次性相关费用的影响,集团经调整后净利润较上年同期实现增长,主营业务盈利保持稳健向好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06667"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0157},{"period":"1month","weight":0.0085},{"period":"3month","weight":-0.0129},{"period":"6month","weight":0.0117},{"period":"1year","weight":0.0117},{"period":"ytd","weight":0.0117}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":-0.1146},{"period":"3month","weight":-0.0821},{"period":"6month","weight":-0.1247},{"period":"1year","weight":-0.0482},{"period":"ytd","weight":-0.1005}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"美因基因有限公司是一家主要提供基因检测服务及癌症筛查服务的投资控股公司。该公司主要通过消费级基因检测分部和癌症筛查服务分部开展业务。该公司的检测服务包括脑健康评估检测套餐、营养吸收能力评估检测套餐、帕金森病风险评估、全面癌症风险评估套餐、心脑血管疾病风险评估套餐等。该公司也提供体外诊断(IVD)管线产品,包括消费级基因检测产品和疾病筛查产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.166378},{"month":2,"riseRate":0.75,"avgChangeRate":0.055076},{"month":3,"riseRate":0,"avgChangeRate":-0.048593},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.010548},{"month":5,"riseRate":0.666667,"avgChangeRate":0.005636},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.015012},{"month":7,"riseRate":0.25,"avgChangeRate":0.007447},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.078161},{"month":9,"riseRate":0,"avgChangeRate":-0.165911},{"month":10,"riseRate":0,"avgChangeRate":-0.078395},{"month":11,"riseRate":0.333333,"avgChangeRate":0.114508},{"month":12,"riseRate":0.666667,"avgChangeRate":0.22092}],"exchange":"SEHK","name":"美因基因","nameEN":"MEGA GENOMICS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}